Increasing Serum Albumin in Dialysis Patients
The best approach to increase serum albumin in dialysis patients is to ensure adequate protein intake (1.2-1.3 g/kg/day for peritoneal dialysis, 1.2 g/kg/day for hemodialysis), maintain adequate dialysis clearance, prevent and treat catabolic illness, and address specific nutritional barriers—not albumin infusion, which is not recommended for dialysis patients. 1, 2
Primary Treatment Strategy
The foundation of managing hypoalbuminemia in dialysis patients involves three core interventions that should be implemented simultaneously:
1. Optimize Nutritional Intake
- Target protein intake of 1.2-1.3 g/kg body weight/day for peritoneal dialysis patients due to significant protein losses in dialysate 1
- Target protein intake of 1.2 g/kg/day for hemodialysis patients 1
- Ensure adequate caloric intake of 35 kcal/kg/day for patients under 60 years, or 30-35 kcal/kg/day for those 60 years and older 1
- Aim for normalized protein nitrogen appearance (nPNA) ≥0.9 g/kg/day, which indicates adequate protein intake in the absence of significant comorbidity 1
- Monitor nutritional status frequently with a renal dietitian to ensure dietary goals are being met 1
2. Ensure Adequate Dialysis Clearance
- Maintain Kt/Vurea at or above recommended targets (typically Kt/Vurea of 2.0 for peritoneal dialysis) 1
- Monitor serum albumin at least every 4 months, with more frequent monitoring during acute illness or when albumin is declining 1, 2
- Evaluate dialysis prescription if albumin is declining despite adequate nutrition, as inadequate clearance may suppress appetite and protein intake 1
3. Prevent and Treat Catabolic Illness
- Identify and treat underlying inflammation, as inflammatory cytokines directly suppress hepatic albumin synthesis even with adequate protein intake 2, 3
- Measure C-reactive protein or other inflammatory markers to distinguish inflammation-driven hypoalbuminemia from pure malnutrition 2, 3
- Treat infections, peritonitis, and other acute illnesses promptly as these drive catabolism 1
Addressing Specific Barriers to Albumin Improvement
A targeted intervention addressing patient-specific nutritional barriers has been shown to increase albumin levels by 0.21 g/dL over 12 months compared to usual care 4. Key barriers to address include:
- Poor nutritional knowledge: Provide education on high-protein foods and dietary requirements 4
- Poor appetite: Consider prokinetic agents if delayed gastric emptying is present, as this can increase albumin from 3.1 to 3.5 g/dL over 6 months 5
- Help needed with shopping or cooking: Arrange social services or meal delivery 4
- Difficulty swallowing: Refer to speech therapy and modify food textures 4
- Gastrointestinal symptoms: Evaluate for gastroparesis, constipation, or other GI issues 4, 5
- Metabolic acidosis: Correct with bicarbonate supplementation 1, 4
Dialyzer Membrane Considerations
For hemodialysis patients using bioincompatible membranes (such as cuprammonium), switching to biocompatible membranes (such as polysulfone) can increase serum albumin levels from 3.22 to 3.35 g/dL 6. However, avoid protein-leaking or medium cut-off membranes that increase albumin losses into dialysate, as approximately 60% of HD patients already have albumin <4.0 g/dL 7.
What NOT to Do
Albumin infusion is explicitly not recommended for dialysis patients for prevention or treatment of intradialytic hypotension or to increase serum albumin levels 2. The evidence shows:
- Increasing dialysis dose (Kt/Vurea) increases protein intake but does not consistently increase serum albumin 1
- There are no convincing data that increasing small-molecule clearance improves nutritional status or serum albumin 1
- Albumin infusion is expensive ($130/25g) and carries risks including fluid overload, hypotension, and anaphylaxis 2
Target Goals and Monitoring
- Target serum albumin ≥4.0 g/dL (using bromcresol green method) as the highest albumin level possible should be the goal 1, 2
- A stable or rising albumin value is desirable, as each 0.1 g/dL decrease is associated with 6% increased death risk and 5% increased hospitalization days 1, 3
- Monitor in context of overall clinical status including comorbid diseases, peritoneal transport type, delivered dialysis dose, and inflammation markers 1
Common Pitfalls to Avoid
- Assuming hypoalbuminemia is solely due to malnutrition when inflammation may be the primary driver—always measure inflammatory markers 2, 3
- Failing to recognize that albumin synthesis is suppressed by catabolic illness even with adequate protein intake 2, 3
- Not addressing fluid overload, as hemodilution from excess fluid decreases serum albumin concentration 3
- Overlooking gastroparesis, particularly in diabetic patients, which can prevent adequate nutrient absorption despite adequate intake 5